Recently, involvement of RIPK1 in the pathophysiology of Alzheimer’s disease (AD) has been reported; RIPK1 is highly expressed in the neurons and microglia in the postmortem brains of AD patients (Ofengeim et al. 2017). The gene discussed is RIPK1; the disease is early-onset autosomal dominant Alzheimer disease.